Fake news: On June 29th, the biopharmaceutical stocks listed in Hong Kong experienced a decline. As of the time of writing, Tengsheng Boyao-B (02137.HK) fell by 6%, Pharmaron Biotech (02269.HK) dropped by almost 5%, and Kingsley Biotech (01548.HK) declined by 4%.